Host and virological characteristics of patients with hepatitis C virus mixed genotype 1 and 2 infection

被引:4
|
作者
Huang, Chung-Feng [1 ,2 ]
Huang, Ching-I [1 ,3 ]
Yeh, Ming-Lun [3 ]
Huang, Jee-Fu [3 ,4 ]
Hsieh, Ming-Yen [3 ]
Lin, Zu-Yau [3 ,4 ]
Chen, Shinn-Cherng [3 ,4 ]
Yu, Ming-Lung [3 ,4 ]
Dai, Chia-Yen [3 ,4 ,5 ,6 ]
Chuang, Wan-Long [3 ,4 ]
机构
[1] Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan
[2] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Dept Occupat Med, Kaohsiung, Taiwan
[3] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan
[4] Kaohsiung Med Univ, Coll Med, Fac Internal Med, Sch Med, Kaohsiung, Taiwan
[5] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Occupat Med, Kaohsiung, Taiwan
[6] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Prevent Med, Kaohsiung, Taiwan
关键词
Genotype; Hepatitis C virus; Interleukin-28B; Mixed infection; INTERLEUKIN-28B GENETIC-VARIANTS; HEPATOCELLULAR-CARCINOMA; RIBAVIRIN THERAPY; VIRAL-HEPATITIS; HCV; INTERFERON; IL28B; SUPERINFECTION; POLYMORPHISMS; ASSOCIATION;
D O I
10.1016/j.kjms.2015.02.004
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The prevalence and characteristics of patients with hepatitis C virus mixed genotype 1 and 2 infection (HCV-1/ 2) remains unclear. For each HCV-1/ 2 patient with histological data available, two age-and sex-matched HCV-1 and HCV-2 infected patients were selected for comparison, respectively. Of the 2776 patients, 261 (9.4%) patients were identified as having mixed HCV-1/ 2 infection. The histological severity did not differ among HCV-1/ 2 patients and controls. The proportion of patients with the interleukin-28B (IL-28B) rs8099917 TT genotype did not differ between patients with mixed-1/ 2 and HCV-1 infection (82.6% vs. 86.5%, p = 0.38). However, HCV-2 infected patients had a significantly higher proportion of the rs8099917 TT genotype compared to patients with mixed HCV-1/ 2 infections (91.6% vs. 82.6%, p = 0.03). The HCV RNA levels were similar in patients with HCV-1/ 2 and HCV-1 infections (5.5 +/- 0.8 log IU/mL vs. 5.5 +/- 0.9 log IU/L, p = 0.73), which were both significantly higher than that of HCV-2 infection (5.1 +/- 0.9 log IU/mL, both p < 0.001). Linear regression analysis revealed that the factors of HCV-1/2 infection [beta: 0.204; 95% confidence interval (CI): 0.183-0.598, p < 0.001], bodyweight(beta:0.150;CI: 0.003-0.021, p = 0.008), and age (beta: - 0.139; CI: - 0.020 to - 0.002, p = 0.01) were independently correlated with HCV RNA levels in patients with HCV-2 and mixed HCV-1/2 infection. We concluded that the host genetic and viral presentations of patients with mixed HCV-1/2 infection were more similar to those of patients with HCV-1 infection than patients with HCV-2 infection. Copyright (C) 2015, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights reserved.
引用
收藏
页码:271 / 277
页数:7
相关论文
共 50 条
  • [31] Predictors of sustained virological response in Greek and Egyptian patients with hepatitis C genotype 4: Does ethnicity matter?
    Papastergiou, Vasilios
    Dimitroulopoulos, Dimitrios
    Skorda, Lamprini
    Lisgos, Philippos
    Ketikoglou, Ioannis
    Kostas, Nikolaos
    Karatapanis, Stylianos
    JOURNAL OF MEDICAL VIROLOGY, 2012, 84 (08) : 1217 - 1223
  • [32] Sofosbuvir for Chronic Hepatitis C Virus Infection Genotype 1-4 in Patients Coinfected With HIV
    Rodriguez-Torres, Maribel
    Gaggar, Anuj
    Shen, Gong
    Kirby, Brian
    Svarovskaia, Evguenia
    Brainard, Diana
    Symonds, William T.
    McHutchison, John G.
    Gonzalez, Milagros
    Rodriguez-Orengo, Jose
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 68 (05) : 543 - 549
  • [33] Genotype 4 hepatitis C virus-a review of a diverse genotype
    Brzdek, Michal
    Dobrowolska, Krystyna
    Flisiak, Robert
    Zarebska-Michaluk, Dorota
    ADVANCES IN MEDICAL SCIENCES, 2023, 68 (01): : 54 - 59
  • [34] Clinical and epidemiological characteristics of Korean patients with hepatitis C virus genotype 6
    Seong, Mun Hyuk
    Kil, Ho
    Kim, Jong Yeop
    Lee, Sang Soo
    Jang, Eun Sun
    Kim, Jin-Wook
    Jeong, Sook-Hyang
    Kim, Young Seok
    Bae, Si Hyun
    Lee, Youn Jae
    Lee, Han Chu
    Yun, Haesun
    Kang, Byung Hak
    Kim, Kisang
    CLINICAL AND MOLECULAR HEPATOLOGY, 2013, 19 (01) : 45 - 50
  • [35] HIV infection and hepatitis C virus genotype 1 a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection
    Bartlett, Sofia R.
    Jacka, Brendan
    Bull, Rowena A.
    Luciani, Fabio
    Matthews, Gail V.
    Lamoury, Francois M. J.
    Hellard, Margaret E.
    Hajarizadeh, Behzad
    Teutsch, Suzy
    White, Bethany
    Maher, Lisa
    Dore, Gregory J.
    Lloyd, Andrew R.
    Grebely, Jason
    Applegate, Tanya L.
    INFECTION GENETICS AND EVOLUTION, 2016, 37 : 252 - 258
  • [36] Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infection
    Suda, Goki
    Hasebe, Chitomi
    Abe, Masami
    Kurosaki, Masayuki
    Itakura, Jun
    Izumi, Namiki
    Uchida, Yoshihito
    Mochida, Satoshi
    Haga, Hiroaki
    Ueno, Yoshiyuki
    Abe, Kazumichi
    Takahashi, Atsushi
    Ohira, Hiromasa
    Tsukuda, Yoko
    Furuya, Ken
    Baba, Masaru
    Yamamoto, Yoshiya
    Kobayashi, Tomoe
    Inoue, Jun
    Terasita, Katsumi
    Ohara, Masatsugu
    Kawagishi, Naoki
    Izumi, Takaaki
    Nakai, Masato
    Sho, Takuya
    Natsuizaka, Mitsuteru
    Morikawa, Kenichi
    Ogawa, Koji
    Sakamoto, Naoya
    Yoshida, Junichi
    Nagasaka, Atsushi
    Fuzinaga, Akira
    Kikuchi, Hideaki
    Atarashi, Tomofumi
    Furuya, Ken
    Muto, Shuichi
    Meguro, Takashi
    Saga, Akiyoshi
    Okamoto, Munenori
    Katagiri, Masaki
    Miyagishima, Takuto
    Konno, Jun
    Kumagai, Kenichi
    Onodera, Manabu
    Kobayashi, Tomoe
    Uebayashi, Minoru
    Katou, Kanji
    Kunieda, Yasuyuki
    Tateyama, Miki
    Kawakami, Atsuhiko
    JOURNAL OF GASTROENTEROLOGY, 2019, 54 (07) : 641 - 649
  • [37] Long-term virological follow up of patients with occult hepatitis C virus infection
    Castillo, Inmaculada
    Bartolome, Javier
    Quiroga, Juan A.
    Barril, Guillermina
    Carreno, Vicente
    LIVER INTERNATIONAL, 2011, 31 (10) : 1519 - 1524
  • [38] Daclatasvir and asunaprevir combination therapy for patients with chronic hepatitis C virus genotype 1b infection in real world
    Oh, Jae Young
    Kim, Byung Seok
    Lee, Chang Hyeong
    Song, Jeong Eun
    Lee, Heon Ju
    Park, Jung Gil
    Hwang, Jae Seok
    Chung, Woo Jin
    Jang, Byoung Kuk
    Kweon, Young Oh
    Tak, Won Young
    Park, Soo Young
    Jang, Se Young
    Suh, Jeong Ill
    Kwak, Sang Gyu
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (04) : 794 - 801
  • [39] IL28B polymorphisms predict the virological response to standard therapy in patients with chronic hepatitis C virus genotype 4 infection
    Abdo, Ayman A.
    Al-Ahdal, Mohammed N.
    Khalid, Saira S.
    Helmy, Ahmed
    Sanai, Faisal M.
    Alswat, Khalid
    Al-hamoudi, Waleed
    Ali, Safiyya M.
    Al-Ashgar, Hamad I.
    Al-Mdani, Abdallah
    Albenmousa, Ali
    Al Faleh, Faleh Z.
    Al-Anazi, Mashael
    Khalaf, Nisreen
    Al-Qahtani, Ahmed
    HEPATOLOGY INTERNATIONAL, 2013, 7 (02) : 533 - 538
  • [40] Efficacy and safety of direct-acting antivirals for treatment-naive patients with genotype 1 hepatitis C virus infection
    Zhu, Xiaobo
    Wang, Mingqi
    Liu, Mei
    Yu, Xinghao
    Huang, Peng
    PERSONALIZED MEDICINE, 2019, 16 (05) : 421 - 429